Avadel Pharmaceuticals gains 1.6% after a favorable court ruling in its narcolepsy drug dispute with Jazz Pharma. See how ...

Avadel Pharmaceuticals plc (NASDAQ:AVDL) just released its latest quarterly results and things are looking bullish. Revenues and losses per share were both better than expected, with revenues of ...

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of Directors approved the ...

DUBLIN — DUBLIN — Avadel Pharmaceuticals PLC (AVDL) on Wednesday reported a loss of $4.9 million in its first quarter. The Dublin-based company said it had a loss of 5 cents per share. The results ...

Analysts are estimating that Avadel Pharmaceuticals will report an earnings per share (EPS) of $-0.06. Avadel Pharmaceuticals ...

In a precedential decision issued May 6, 2025, the Federal Circuit reversed in part and vacated in part a Delaware district ...

Update 1:15pm: Adds company, analyst comment. Avadel Pharmaceuticals (NASDAQ:AVDL) seesawed after an appeals court ruling in a dispute with Jazz Pharmaceuticals (NASDAQ:JAZZ) over narcolepsy drug ...

DUBLIN, May 08, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee ...

DUBLIN - Avadel Pharmaceuticals plc (NASDAQ:AVDL), a biopharmaceutical company with impressive revenue growth of over 500% in the last twelve months and a market capitalization of $874 million ...